Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Sep 1:130:159-161.
doi: 10.1016/j.amjcard.2020.05.038. Epub 2020 Jun 2.

A Meta-analysis of the Relationship Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19

Muhammad Shariq Usman  1 , Tariq Jamal Siddiqi  2 , Muhammad Shahzeb Khan  3 , Areeba Ahmed  2 , Syed Saad Ali  2 , Erin D Michos  4 , Michael E Hall  5 , Richard A Krasuski  6 , Stephen J Greene  6 , Javed Butler  5 , Mohamad Alkhouli  7
Affiliations
Meta-Analysis

A Meta-analysis of the Relationship Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19

Muhammad Shariq Usman et al. Am J Cardiol. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Forest plots displaying the odds of (A) testing positive for COVID-19 amongst patients using ACEI, compared to those not using ACEI; (B) testing positive for COVID-19 amongst patients using ARBs, compared to those not using ARBs; (C) mortality in COVID-19 patients using RAAS inhibitors, compared to those not using RAAS inhibitors.
See this image and copyright information in PMC

References

    1. Vaduganathan M, Vardeny O, Michel T, McMurray JJ, Pfeffer MA, Solomon SD. Renin–angiotensin–aldosterone system inhibitors in patients with Covid-19. N Engl J Med. 2020;382:1653–1659. - PMC - PubMed
    1. Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G. Renin–angiotensin–aldosterone system blockers and the risk of Covid-19. N Engl J Med. 2020;382:2431–2440. - PMC - PubMed
    1. Mehta N, Kalra A, Nowacki AS, Anjewierden S, Han Z, Bhat P, Carmona-Rubio AE, Jacob M, Procop GW, Harrington S, Milinovich A, Svensson LG, Jehi L, Young JB, Chung MK. Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020 Published online on May 05, 2020. - PMC - PubMed
    1. Meng J, Xiao G, Zhang J, He X, Ou M, Bi J. Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension. Emerg Microbes Infect. 2020;9:757–760. - PMC - PubMed
    1. Peng YD, Meng K, Guan HQ, Leng L, Zhu RR, Wang BY. [Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV] Zhonghua Xin Xue Guan Bing Za Zhi. 2020;48:E004. - PubMed

Substances